Ovarian hyperstimulation syndrome: a clinical retrospective study on 565 inpatients

References

• Youssef MA, Mourad S. Volume expanders for the prevention of ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2016;CD001302.
   PubMed Web of Science ®Google Scholar
• Dey AK, Dubey A, Mittal K, et al. Spontaneous ovarian hyperstimulation syndrome – understanding the dilemma. Gynecol Endocrinol. 2015;31:587–589.
   PubMed Web of Science ®Google Scholar
• Kwik M, Maxwell E. Pathophysiology, treatment and prevention of ovarian hyperstimulation syndrome. Curr Opin Obstet Gynecol. 2016;28:236–241.
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Electronic address, A.a.o. and M. Practice Committee of the American Society for Reproductive, Prevention and Treatment of Moderate and Severe Ovarian Hyperstimulation Syndrome: a guideline. Fertil Steril. 2016;106:1634–1647.
   PubMed Web of Science ®Google Scholar
• Mathur RS, Akande AV, Keay SD, et al. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril. 2000;73:901–907.
   PubMed Web of Science ®Google Scholar
• Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012;10:32.
   PubMed Web of Science ®Google Scholar
• Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8:559–577.
   PubMed Web of Science ®Google Scholar
• Wu L, Sun Y, Wan J, et al. A proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients. Mol Med Rep. 2017;16:272–280.
   PubMed Web of Science ®Google Scholar
• Ghasemi N, Dehghani Firouzabadi R, Ahmadi S. Association of -460C/T and +405 G/C polymorphisms of vascular endothelial growth factor gene and susceptibility to ovarian hyperstimulation syndrome. Int J Reprod Biomed. 2017;15:87–92.
   PubMed Web of Science ®Google Scholar
• Abuzeid M, Warda H, Joseph S, et al. Outpatient management of severe ovarian hyperstimulation syndrome (OHSS) with placement of pigtail catheter. Facts Views Vis Obgyn. 2014;6:31–37.
   PubMedGoogle Scholar
• Gebril A, Hamoda H, Mathur R. Outpatient management of severe ovarian hyperstimulation syndrome: a systematic review and a review of existing guidelines. Hum Fertil (Camb). 2018;21:98–105.
   PubMed Web of Science ®Google Scholar
• Navot D, Relou A, Birkenfeld A, et al. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 1988;159:210–215.
   PubMed Web of Science ®Google Scholar
• Sousa M, Cunha M, Teixeira da Silva J, et al. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles. Reprod Biol Endocrinol. 2015;13:66.
   PubMed Web of Science ®Google Scholar
• Ng EH, Tang OS, Ho PC. The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme. Hum Reprod. 2000;15:1937–1942.
   PubMed Web of Science ®Google Scholar
• Doldi N, Persico P, Di Sebastiano F, et al. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer. Gynecol Endocrinol. 2006;22:235–238.
   PubMed Web of Science ®Google Scholar
• Xu GF, Zhou CL, Xiong YM, et al. Reduced intellectual ability in offspring of ovarian hyperstimulation syndrome: a cohort study. EBioMedicine. 2017;20:263–267.
   PubMed Web of Science ®Google Scholar
• Gil Navarro N, Garcia Grau E, Pina Perez S, et al. Ovarian torsion and spontaneous ovarian hyperstimulation syndrome in a twin pregnancy: a case report. Int J Surg Case Rep. 2017;34:66–68.
   PubMed Web of Science ®Google Scholar
• Mai Q, Hu X, Yang G, et al. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial. Am J Obstet Gynecol. 2017;216:42 e142 e10.
   PubMed Web of Science ®Google Scholar
• Jacob SL, Brewer C, Tang T, et al. A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial. Hum Reprod. 2016;31:2756–2764.
   PubMed Web of Science ®Google Scholar
• Soares SR, Gomez R, Simon C, et al. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update. 2008;14:321–333.
   PubMed Web of Science ®Google Scholar
• Lyons CA, Wheeler CA, Frishman GN, et al. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod. 1994;9:792–799.
   PubMed Web of Science ®Google Scholar
• Shields R, Vollenhoven B, Ahuja K, et al. Ovarian hyperstimulation syndrome: a case control study investigating risk factors. Aust N Z J Obstet Gynaecol. 2016;56:624–627.
   PubMed Web of Science ®Google Scholar